[Genomics BioSci & Tech. Co., Ltd.] 2026 Q1 EPS -0.54 NTD
Genomics BioSci reported a net loss for 2026 Q1 with an EPS of -0.54 NTD and revenue of 152 million … · 2026-03-01
Genomics BioSci reported a net loss for 2026 Q1 with an EPS of -0.54 NTD and revenue of 152 million … · 2026-03-01
Genomics BioSci reported a net loss for 2026 Q1 with an EPS of -0.54 NTD and revenue of 152 million … · 2026-03-01